"Clearside Biomedical is delighted to have a partnership with the seasoned Hatteras investment team and their extensive experience in building healthcare companies"

Daniel White, CEO
image

WATCH THE VIDEO

Seeing is believing.
Although, you
probably won't believe
your eyes.

ON THE HORIZON

2/28/2012 - 4th Ocular Disease and Drug Discovery Conference

2/28/2012 - International Masters of Retina meeting.

HINDSIGHT IS 20/20

Yet some investment
opportunities are very
clear right from
the start.